Chigasaki, Japan

Shin-ichi Hirano


Average Co-Inventor Count = 10.4

ph-index = 3

Forward Citations = 62(Granted Patents)


Company Filing History:


Years Active: 1993-2003

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Shin-ichi Hirano

Introduction

Shin-ichi Hirano is a notable inventor based in Chigasaki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on salicylamide and isocoumarin derivatives. With a total of 4 patents to his name, Hirano's inventions have the potential to impact medical treatments significantly.

Latest Patents

Hirano's latest patents include the development of salicylamide derivatives, which are represented by specific formulae. These derivatives serve as intermediates in production processes and are incorporated into drugs as active ingredients. They are particularly useful as anti-inflammatory and immunosuppressive agents, effectively inhibiting the activation of NF-κB with minimal side effects. Additionally, he has worked on isocoumarin derivatives, which also have applications in drug development.

Career Highlights

Throughout his career, Hirano has been associated with reputable organizations such as Mercian Corporation and Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai. His work in these companies has allowed him to explore and develop innovative solutions in the pharmaceutical industry.

Collaborations

Hirano has collaborated with notable colleagues, including Takeo Yoshioka and Hiroshi Iguchi. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Shin-ichi Hirano's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…